HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxidative Stress Contributes to Status Epilepticus Associated Mortality.

Abstract
Status epilepticus is a common manifestation of nerve agent toxicity and represents a serious medical emergency with high rates of mortality and neurologic injury in those that survive. The aim of the current study was to determine if targeting oxidative stress with the catalytic antioxidant, AEOL10150, would reduce pilocarpine-induced mortality and attenuate neuronal death and neuroinflammation. We found that treatment with AEOL10150 in conjunction with scopolamine and diazepam following pilocarpine-induced SE was able to significantly reduce mortality compared to treatment with just scopolamine and diazepam. Mortality was further reduced when AEOL10150 was used in conjunction with atropine and diazepam which is considered the standard of care for nerve agent exposures. Both treatment paradigms offered significant protection against SE-induced oxidative stress. Additionally, treatment with scopolamine, AEOL10150 and diazepam attenuated SE-induced neuronal loss and neuroinflammation. Taken together, the data suggest that pharmacological targeting of oxidative stress can improve survival and attenuate secondary neurological damage following SE induced by the nerve agent surrogate pilocarpine.
AuthorsJennifer N Pearson-Smith, Li-Ping Liang, Shane D Rowley, Brian J Day, Manisha Patel
JournalNeurochemical research (Neurochem Res) Vol. 42 Issue 7 Pg. 2024-2032 (Jul 2017) ISSN: 1573-6903 [Electronic] United States
PMID28462450 (Publication Type: Journal Article)
Chemical References
  • Anticonvulsants
  • Antioxidants
  • Pilocarpine
Topics
  • Animals
  • Anticonvulsants (pharmacology, therapeutic use)
  • Antioxidants (pharmacology, therapeutic use)
  • Hippocampus (drug effects, metabolism)
  • Male
  • Oxidative Stress (drug effects, physiology)
  • Pilocarpine (toxicity)
  • Rats
  • Rats, Sprague-Dawley
  • Status Epilepticus (drug therapy, metabolism, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: